- Report
- October 2025
- 194 Pages
Global
From €5193EUR$5,850USD£4,527GBP
- Report
- September 2025
- 250 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- June 2025
- 400 Pages
Global
From €4393EUR$4,949USD£3,830GBP
- Report
- September 2025
- 150 Pages
Global
From €3417EUR$3,850USD£2,980GBP
- Report
- August 2025
- 495 Pages
Global
From €4394EUR$4,950USD£3,831GBP
- Report
- February 2025
- 150 Pages
Global
From €5281EUR$5,950USD£4,605GBP
- Report
- September 2025
- 138 Pages
Global
From €2662EUR$2,999USD£2,321GBP
- Report
- September 2025
- 130 Pages
Global
From €5281EUR$5,950USD£4,605GBP
- Report
- October 2025
- 193 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 187 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 197 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- August 2025
- 193 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- April 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,475GBP
- Report
- February 2025
- 183 Pages
Global
From €3994EUR$4,500USD£3,483GBP
- Report
- October 2025
- 193 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 181 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 197 Pages
Global
From €3147EUR$3,545USD£2,744GBP
€3496EUR$3,939USD£3,048GBP
- Report
- October 2025
- 484 Pages
Global
From €5193EUR$5,850USD£4,527GBP
- Report
- October 2025
- 475 Pages
Global
From €5193EUR$5,850USD£4,527GBP
- Report
- September 2025
- 87 Pages
Global
From €3500EUR$4,224USD£3,158GBP

The Viral Clearance market is a subset of the biotechnology industry that focuses on the development of technologies and processes to reduce the presence of viruses in biopharmaceutical products. This is done through the use of viral clearance strategies such as filtration, chromatography, and inactivation. These strategies are used to reduce the risk of contamination and ensure the safety of biopharmaceutical products.
Viral clearance is an important part of the biopharmaceutical manufacturing process, as it helps to ensure the safety and efficacy of the products. It is also used to reduce the risk of cross-contamination between batches of biopharmaceuticals.
Some companies in the Viral Clearance market include Merck, Sartorius, Pall Corporation, and Thermo Fisher Scientific. Show Less Read more